Whalegun
Home

Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 24/10/22

Trade details

Type
Insider sale
Amount
$24,510
Shares · price
817 sh · $30.00 a share
Held after
123,673 sh
Stock
Enliven Therapeutics ELVN
Person
Richard A. HeymanDirector
Trade date
24/10/18
Filed
24/10/22
Days to filing
4 days

Sold 0.7% of holdings

Share of holding sold
0.7%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/18~24/11/17

Richard A. Heyman's recent trades

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $109.1K

    Filed 10/01

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $102.4K

    Filed 10/01

  • Richard A. Heyman

    Planned saleEnliven Therapeutics

    $2.3M

    Filed 09/04

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $84K

    Filed 07/06

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $76.8K

    Filed 07/06

Richard A. Heyman, Director — sold $24.5K of Enliven Therapeutics ELVN · 0.7% of holdings · 10b5-1 plan | Whalegun